This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Arthrogryposis Multiplex Congenita선천성 다발관절만곡증 (선천성다발관절만곡증)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q74.3 | Special Copayment Reduction: V292 (rare disease Special Copayment Reduction)
B. SynonymsArthrogryposis multiplex congenita
C. Adult onsetPossibility of first onset in adulthood very low — arthrogryposis multiplex congenita is a congenital malformation in which multiple joint contractures are already clearly present at birth, and it is diagnosed in the neonatal period or on prenatal ultrasound before birth. Because the contractures themselves are non-progressive, they do not newly appear in adulthood.
1. History1841 first description by Otto. 1923 Sheldon names it 'Arthrogryposis multiplex congenita'. Late 20th century fetal akinesia hypothesis established. Rapid progress in identifying genetic and neuromuscular causes since the 2000s. Redefined as a group of multiple causative diseases (syndrome spectrum).
2. CausesCommon final mechanism: reduced intrauterine joint movement of the fetus (fetal akinesia). Groups of causes: ① neuromuscular abnormalities (brain, spinal cord, muscle, nerve), ② connective tissue abnormalities, ③ intrauterine space limitation (twins, malformed uterus, oligohydramnios), ④ abnormal vascular supply, ⑤ maternal disease (myasthenia gravis, multiple sclerosis). Genetic cause identified in about 35%.
3. GeneticsAmong about 35% with hereditary causes, autosomal recessive (AR) is most common. Related genes: PIEZO2, BICD2, TNNT3, TPM2, MYH3 (DA2B), RYR1, DYNC1H1, etc. Marked genetic heterogeneity (locus heterogeneity). Some X-linked forms (AMC + hydrocephalus: FLNA). Diagnostic yield of whole exome/genome analysis (WES/WGS) 35–50%.
4. General epidemiologyAbout 1 in 3,000 births (all congenital arthrogryposis syndromes). By the traditional AMC definition, 1 in 5,000–10,000 births. No sex difference. Some ethnic and regional clustering (increased in populations with frequent consanguineous marriage). Korea: ultra-rare disease, estimated at a few dozen new patients per year.
5. PathophysiologyWhen normal movement of fetal joints decreases during pregnancy, the surrounding soft tissues (joint capsule, ligaments, tendons, muscles) become fibrotic and shortened. Increased periarticular fat, impaired joint development. Divided into neurogenic, myogenic, structural, and mechanical factors according to the cause of reduced joint movement. The longer the fetal akinesia and the earlier its onset, the more severe the contractures.
6. SymptomsMultiple joint contractures (2 or more body areas). Typical AMC: shoulder adduction and internal rotation, elbow extension contracture, wrist and finger flexion, hip dislocation and flexion, knee flexion or extension, clubfoot (talipes equinovarus) common. Muscle atrophy, skin webbing (pterygium). Intelligence mostly normal.
7. SignsMultiple joint flexion and extension contractures. Muscle hypoplasia and symmetric atrophy. Skin webbing (pterygium). Reduced skin creases over joints (loss of skin creases). Cylindrical limbs. Hip dislocation, scoliosis. Decreased or absent reflexes (neurogenic causes). Facial asymmetry (jaw contracture, ptosis) in some.
8. ScreeningPrenatal ultrasound (after 16 weeks of gestation): findings suggesting reduced fetal movement, fixed joint posture, hand and foot abnormalities, polyhydramnios. Additional evaluation with fetal MRI. Molecular genetic prenatal diagnosis (CVS/amniocentesis) when there is a family history. Neonatal period: immediate multidisciplinary evaluation when multiple joint contractures are confirmed.
9. DiagnosisClinical diagnosis: congenital contractures (non-progressive) of 2 or more joints. Cause evaluation: whole exome (WES) or whole genome (WGS) sequencing, electromyography (EMG), nerve conduction studies, muscle biopsy, brain and spinal cord MRI, metabolic testing. Diagnostic classification: Hall classification (whether the central nervous system is involved). Differentiating the cause is important for estimating recurrence risk.
10. TreatmentEarly intensive physical therapy (passive stretching, splinting). Serial casting from the neonatal period through infancy (Ponseti method, clubfoot). Surgery: tendon transfer and lengthening, capsulotomy, closed reduction of the hip and pelvic osteotomy, scoliosis correction. Long-term use of orthoses (AFO, KAFO). Integrated multidisciplinary treatment (orthopedics, rehabilitation medicine, occupational therapy, psychological counseling).
11. PrognosisIntelligence and cognitive function mostly normal. Ability to walk independently and perform daily activities varies with the degree of contracture. Functional prognosis greatly improved with early intensive rehabilitation. Employment and social participation in adulthood possible in many cases. Severe contractures, associated malformations (heart, kidney), and respiratory failure are prognostic determinants. Contractures are non-progressive but may recur with growth.
12. PreventionFamily counseling and prenatal diagnosis for genetic causes. Appropriate treatment of maternal neuromuscular disease (myasthenia gravis, etc.). Early detection and management of oligohydramnios. Counseling on the risk of multiple pregnancy with assisted reproduction. Prevention of recurrence after surgery: continued wearing of splints and orthoses. Early detection and correction of scoliosis and hip dislocation through regular follow-up during growth.
13. ReferencesHall JG. Arthrogryposis multiplex congenita: etiology, genetics, classification, diagnostic approach, and general aspects. J Pediatr Orthop B. 1997 … and 9 other references

1. History

The first systematic description of Arthrogryposis Multiplex Congenita (AMC) was made in 1841 by the German anatomist Adolph Wilhelm Otto. Reporting cases of newborns with multiple joint contractures, Otto recognized it as a separate entity distinct from 'congenital muscular torticollis'. However, at the time there was no understanding of its cause or classification, and similar cases appeared intermittently in the literature over the following decades.

The currently used name 'Arthrogryposis Multiplex Congenita' was first proposed in 1923 by the American pediatrician William Sheldon. Combining the Greek for joint (arthron) and bending (gryposis) with multiple (multiplex) and congenital (congenita), the name intuitively conveys the clinical features of the disease. Sheldon presumed at the time that the condition was due to abnormal muscle development, but later studies showed that a variety of abnormalities throughout the neuromuscular system can cause the same phenotype.

From the mid-20th century, understanding of the pathogenesis of AMC deepened. In the 1960s–70s, several researchers proposed that reduced fetal joint movement is the key mechanism of contractures, which is called the fetal akinesia-deformation sequence. In particular, Judith Hall of Canada, who has made the greatest international contribution to AMC research, carried out extensive research from 1981 over several decades on the classification, causes, genetics, and prognosis of AMC, establishing the foundation of the modern understanding of AMC. Hall emphasized that AMC is not a single disease but a syndrome spectrum caused by more than 300 different causes.

In the 21st century, the introduction of next-generation sequencing (NGS) technology rapidly advanced the identification of the genetic causes of AMC. AMC-related genes such as PIEZO2, BICD2, MYH3, TPM2, TNNT3, and RYR1 were identified one after another, and in distal arthrogryposis (DA) in particular, variants in genes for proteins of the muscle contractile apparatus were confirmed as major causes. AMC is now understood as a complex syndrome caused by at least about 400 different genetic and environmental causes, and precise etiological diagnosis for individual patients plays a key role in treatment, counseling, and prognosis prediction. In Korea as well, AMC patient registration and multidisciplinary treatment systems are developing at major medical institutions such as Asan Medical Center and Samsung Medical Center.

2. Causes

The core pathogenesis of arthrogryposis multiplex congenita is reduced intrauterine joint movement of the fetus (fetal akinesia or reduced fetal movement) occurring during fetal development, particularly from early to mid-pregnancy. Joints develop into their normal shape when adequate movement is maintained, and when movement decreases, the periarticular soft tissues (joint capsule, ligaments, tendons, muscles) become fibrotic and shortened, forming contractures. The causes of reduced movement are very diverse and are broadly classified into five categories: neuromuscular abnormalities, connective tissue abnormalities, intrauterine space limitation, abnormal vascular supply, and maternal disease.

Neuromuscular abnormalities: the most common category of causes, divided into central nervous system (cerebrum, cerebellum, spinal cord) abnormalities and peripheral neuromuscular system (anterior horn cells, peripheral nerves, neuromuscular junction, skeletal muscle) abnormalities. Anterior horn cell abnormalities include spinal muscular atrophy (SMA, SMN1 variants), brainstem abnormalities, and developmental abnormalities of the central nervous system. Muscle abnormalities include congenital myopathies (nemaline myopathy, central core disease, myotubular myopathy, etc.), muscular dystrophies, and myotonic myopathies. Among neuromuscular junction abnormalities, congenital myasthenic syndrome can cause AMC, and in maternal myasthenia gravis, maternal anti-AChR antibodies can cross the placenta and block the fetal neuromuscular junction, causing transient reduction in fetal movement.

Connective tissue abnormalities: excessive fibrosis or collagen abnormalities of periarticular connective tissue physically limit joint movement. Some forms of congenital fibrosis fall into this category. Intrauterine space limitation: contractures occur because the fetus's space for movement is physically limited by twin or multiple pregnancy, uterine malformations (double uterus, uterine septum), uterine fibroids, or oligohydramnios. Abnormal vascular supply: placental vascular abnormalities, umbilical cord constriction, complications of amniotic procedures, and the like can cause ischemia of fetal muscles and nerves, leading to reduced movement. Maternal disease: maternal fever (hyperthermia in early pregnancy) and maternal exposure to antiepileptic drugs, alcohol, and muscle relaxants have also been reported as risk factors. A genetic cause is identified in about 35% of all AMC patients, and in the rest the cause is environmental/mechanical or unknown.

3. Genetics

The inheritance pattern of arthrogryposis multiplex congenita varies greatly depending on the causative gene. The most common mode of transmission of hereditary AMC is autosomal recessive (AR), with a high incidence in populations with high rates of consanguineous marriage. Autosomal dominant (AD) inheritance is also common in some subtypes such as distal arthrogryposis (DA), and some cases are due to new (de novo) mutations. Rarely, X-linked inheritance is also observed (e.g., the combined AMC + hydrocephalus form, FLNA gene).

Genes related to distal arthrogryposis (DA): DA is characterized mainly by contractures of the distal limb joints (hands, feet) and is classified into more than 10 subtypes. In DA2B (Freeman-Sheldon syndrome or Sheldon-Hall syndrome), variants in the MYH3 (embryonic skeletal muscle myosin heavy chain), TPM2 (tropomyosin beta), and TNNT3 (troponin T3) genes are the cause, all of which are components of the muscle contractile apparatus. PIEZO2 gene variants are associated with DA5 (DA with scoliosis), and PIEZO2 is a mechanosensory receptor essential for joint position sense (proprioception). Patients with PIEZO2 variants have loss of proprioception, reduced vibration sense, and scoliosis.

Genes related to neurogenic AMC: representative genes related to spinal anterior horn cell abnormalities are SMN1 (spinal muscular atrophy type 1), BICD2 (dynein adaptor protein, anterior horn cell abnormality), DYNC1H1 (intracellular transport protein), and RYR1 (ryanodine receptor 1, a sarcoplasmic reticulum Ca²⁺ channel, associated with central core myopathy). Genes related to congenital myasthenic syndrome: variants in genes for neuromuscular junction functional proteins such as RAPSN, CHRNE, and DOK7 cause the AMC phenotype. The diagnostic yield of whole exome sequencing (WES) in AMC patients is about 35–50%, and it is expected to be higher when whole genome sequencing (WGS) is included. Genetic diagnosis is essential for accurate estimation of recurrence risk, determining whether prenatal diagnosis is possible, and predicting treatment response.

4. General epidemiology

Arthrogryposis multiplex congenita is relatively not uncommon among congenital musculoskeletal malformations, but incidence estimates vary according to the scope of the definition. When joint contracture is broadly defined to include non-progressive congenital contractures of 2 or more joints, it occurs at a frequency of about 1 in 3,000 births. When narrowly defined as AMC in the traditional sense (multi-segment joint contractures with muscle atrophy and skin webbing), it falls to 1 in 5,000–10,000 births.

Overall, sex differences are not large, but some subtypes show a sex bias. In X-linked AMC (such as FLNA gene-related AMC + X-linked hydrocephalus), a severe phenotype expressed only in boys appears. Regional epidemiology: there are reports that the incidence of AMC is higher than in the general population in some regions of the Middle East and South Asia with high rates of consanguineous marriage, reflecting the high proportion of autosomal recessive causes. The incidence is also high in twin and multiple pregnancies.

Epidemiology in Korea: systematic registry data on AMC in Korea are still lacking, but estimates based on Health Insurance Review & Assessment Service (HIRA) data put the number of newly diagnosed patients per year at a few dozen, making it an ultra-rare disease. In Korea, registration for National Health Insurance Special Copayment Reduction (V292) provides reduced medical costs. A clear genetic cause is identified in about 30–35% of AMC patients, and in the rest the cause is environmental/mechanical or unknown. In the unknown-cause group, more causes are expected to be identified in the future with advances in next-generation sequencing technology. Including the spectrum of diseases related to AMC (distal DA, FADS/Lethal, etc.), the number of related patients encountered in actual clinical practice is greater.

Regarding mortality, AMC itself is rarely a direct cause of death, but infant mortality is high in severe AMC with serious associated malformations (cardiac malformations, renal malformations, central nervous system abnormalities) or respiratory failure. In the lethal form of FADS (Fetal Akinesia Deformation Sequence), perinatal death can occur. The life expectancy of surviving patients depends greatly on the type of AMC and the presence of associated malformations, and in cases of non-neurological cause, life expectancy is nearly normal.

5. Pathophysiology

The pathogenesis of arthrogryposis multiplex congenita converges in common on reduced intrauterine joint movement of the fetus (fetal akinesia). In normal joint development, active and passive fetal movements are essential for joint space formation, development of articular surfaces, and normal growth of surrounding soft tissues. When fetal movement, which begins in early pregnancy (7–8 weeks), decreases, the periarticular soft tissues (joint capsule, ligaments, tendons, muscles) become abnormally fibrotic and shortened, and periarticular adipose tissue increases. This fibrotic process is mediated by molecular mechanisms related to TGF-β, collagen deposition, and reduced muscle satellite cell function.

The molecular and cellular mechanisms of reduced joint movement vary by cause. Neurogenic mechanism: abnormalities (degeneration, hypoplasia) of spinal anterior horn cells or peripheral motor nerves block muscle contraction signals, reducing fetal movement. In spinal muscular atrophy (SMA), SMN1 protein deficiency causes selective death of anterior horn cells, and the resulting muscle denervation leads to reduced movement and contractures. Myogenic mechanism: abnormalities of muscle contractile proteins (actin, myosin, troponin, tropomyosin) or of energy metabolism reduce muscle contractile force, reducing fetal movement. In distal AMC, MYH3, TNNT3, and TPM2 variants cause dysfunction of embryonic muscle contractile proteins, resulting in early fetal muscle contraction failure. Mechanical mechanism: intrauterine space limitation (oligohydramnios, uterine malformation, multiple pregnancy) leaves insufficient physical space for fetal movement.

In the tissue-level mechanism by which fetal akinesia leads to contractures, extracellular matrix (ECM) remodeling is central. Normally, hydrodynamic forces during joint movement stimulate synoviocytes and chondrocytes, promoting synthesis of hyaluronic acid and proteoglycans and suppressing excessive collagen accumulation through MMPs (matrix metalloproteinases). When movement decreases, this balance breaks down, deposition of type I and III collagen increases, and fibrosis of the joint capsule and tendon structures progresses. In addition, proliferation of satellite cells in muscle is suppressed, reducing muscle regenerative capacity, and muscle fiber atrophy persists. The earlier the onset and the longer the duration of reduced joint movement, the more severe the contractures.

6. Symptoms

The clinical symptoms of arthrogryposis multiplex congenita vary greatly according to the number and location of affected joints, the direction and degree of contractures, and the presence of associated malformations. The common principle is that joint contractures involving 2 or more body areas are present at birth, and these contractures are non-progressive rather than progressive. Contractures may be fixed in flexion or extension, and both directions may be affected at the same time.

Upper limb symptoms: in typical AMC, upper limb involvement appears as adduction and internal rotation contracture of the shoulder, extension contracture of the elbow, flexion and ulnar deviation contracture of the wrist, and finger flexion and thumb adduction contractures, in that order. Elbow extension contracture makes it difficult to bend the arm, causing difficulty with daily activities such as eating, washing, and writing. Reduced grip function due to hand contractures greatly affects independence in daily living. Skin creases over the joints of the upper limb are reduced or absent, and a cylindrical arm shape is characteristic.

Lower limb symptoms: hip flexion and abduction contracture with dislocation (DDH), knee flexion or extension contracture, and clubfoot (talipes equinovarus) are the most common patterns of lower limb involvement. Clubfoot is present in about 50% of AMC, and because skin and soft tissue contractures are severe, complete correction is often difficult even with Ponseti casting. Hip dislocation has an important effect on the development of walking, so early correction is needed. Knee extension contracture is favorable for walking, but when flexion contracture is severe, independent walking is difficult.

Other symptoms: scoliosis is present in about 20–30% of AMC patients, and when it progresses during growth it also affects respiratory function. Microstomia (a small mouth that does not open well), jaw contracture (trismus), and ptosis appear in some subtypes (especially Freeman-Sheldon syndrome, DA2A). Skin webbing (pterygium colli, popliteal pterygium) appears around joints, further fixing the contractures. Cognitive function and intelligence are mostly normal when there is no accompanying central nervous system abnormality, and this is an important positive prognostic factor for rehabilitation of AMC patients.

7. Signs

The physical signs of arthrogryposis multiplex congenita are immediately apparent on newborn physical examination. The most important sign is joint contractures involving 2 or more body segments, in which joints are fixed in a specific position (flexion or extension) and the range of motion is limited even with external force. The passive range of motion (PROM) of each joint is measured to quantify the degree of contracture and used as a baseline for comparison before and after treatment.

Muscle signs: muscle hypoplasia and symmetric atrophy are prominent in affected limbs. Subcutaneous fat is preserved but muscles do not develop, producing a cylindrical, 'pillar-like' limb shape. Normal skin creases around affected joints are reduced or absent, and conversely skin webbing (pterygium) forms. Deep tendon reflexes are reduced or absent with neurogenic causes and may be preserved with myogenic or mechanical causes.

Hip and spine signs: with hip dislocation, positive Barlow and Ortolani tests, leg length discrepancy, and prominence of the greater trochanter are observed. In AMC, closed reduction of hip dislocation is more difficult than in ordinary developmental dysplasia of the hip because of soft tissue contractures. In scoliosis, spinal curvature is confirmed by inspection and palpation, and a rib hump appears on the forward bending test (Adam's forward bending test). The curve angle (Cobb angle) is measured on spinal X-ray.

Facial and head signs: in some AMC subtypes (especially DA2A, Freeman-Sheldon syndrome), microstomia, jaw contracture (trismus), deep nasolabial folds, ptosis, and strabismus appear as characteristic facial findings. Asymmetric crying face and abnormal development of the facial expression muscles have also been reported. In PIEZO2 variant-related DA5, reduced deep sensation (proprioception, vibration sense) is confirmed on neurological examination. A comprehensive neurological evaluation (cranial nerve function, limb strength, reflexes, sensation, cerebellar function) is important for differentiating accompanying central nervous system abnormalities.

8. Screening

There is no general population newborn screening program for arthrogryposis multiplex congenita. However, detection of fetal abnormalities by prenatal ultrasound functions as the main screening tool, and prenatal genetic diagnosis is applied when there is a family history.

Prenatal ultrasound screening: AMC should be suspected if the following findings are observed on routine ultrasound after 16 weeks of gestation. ① Reduced or absent fetal movement (fetal akinesia), ② persistent abnormal posture (e.g., wrist flexion, foot inversion, fixed knee extension), ③ polyhydramnios (amniotic fluid accumulation due to difficulty swallowing), ④ impaired lung development (reduced breathing movements), ⑤ facial abnormalities (microstomia, abnormal mandibular development). The more distinct the ultrasound findings, the earlier detection is possible, but mild AMC may be missed on prenatal ultrasound.

Fetal MRI: when AMC or a neuromuscular abnormality is suspected on ultrasound, fetal MRI can additionally be performed to evaluate brain and spinal cord structural abnormalities, the degree of muscle development, and joint posture more precisely. It is particularly useful for determining whether there are associated central nervous system malformations. Prenatal genetic diagnosis: when the genetic cause of AMC in the family has already been identified, fetal DNA obtained by chorionic villus sampling (CVS, at 11–14 weeks of gestation) or amniocentesis (at 15–20 weeks of gestation) is analyzed for the relevant gene variant to determine whether the fetus is affected. Preimplantation genetic testing (PGT) is also possible in some families.

Neonatal screening: if multiple joint contractures, abnormal limb posture, or muscle hypoplasia are found on routine newborn physical examination, AMC should be suspected immediately and multidisciplinary evaluation started. Careful physical examination by the obstetrician and neonatologist at delivery is the key to early diagnosis. Because starting physical therapy immediately after birth is important for treatment outcomes, referral for specialist treatment should be made at the same time as screening.

9. Diagnosis

The diagnosis of arthrogryposis multiplex congenita is made through a stepwise approach of clinical findings, imaging, electrodiagnostic testing, muscle biopsy, and molecular genetic testing. The purpose of diagnosis is not only to confirm AMC clinically but also to identify the specific cause for use in estimating recurrence risk, treatment planning, and evaluating associated malformations.

Clinical diagnostic criteria: AMC is defined as ① congenital joint contractures present at or before birth, ② involving 2 or more body areas, ③ that are non-progressive. When these criteria are met, a clinical diagnosis is possible, and additional tests for cause evaluation then follow.

Imaging: X-rays assess the direction and degree of joint contractures, abnormal bone formation, hip dislocation, and scoliosis. MRI is used to assess brain and spinal cord structural abnormalities and muscle morphology and the degree of fatty infiltration. Muscle ultrasound is useful for noninvasively assessing muscle hypoplasia, increased echogenicity, and the degree of fibrosis.

Nerve conduction studies and electromyography (EMG): essential for differentiating neurogenic causes (anterior horn cell abnormalities, peripheral neuropathy) from myogenic causes (myopathies). In neurogenic AMC, reduced motor nerve conduction velocity, fibrillation potentials on EMG, and large motor unit potentials appear. Myogenic AMC is characterized by small polyphasic motor unit potentials and early recruitment.

Muscle biopsy: to differentiate congenital myopathies, muscle tissue is obtained for light microscopy (histochemical staining), electron microscopy, and immunohistochemistry. Nemaline rods are found in nemaline myopathy, central cores in central core disease, and myotubular structural abnormalities in myotubular myopathy.

Molecular genetic testing: whole exome sequencing (WES) or an AMC gene panel test is performed. The current diagnostic yield is about 35–50%, and a higher yield is expected with WGS (whole genome sequencing). When a gene variant is identified, family recurrence risk is estimated by testing parents and siblings. Whether and how prenatal diagnosis is possible is also determined by the results of genetic diagnosis.

10. Treatment

Treatment of arthrogryposis multiplex congenita is provided through the collaboration of a multidisciplinary team including pediatric orthopedics, rehabilitation medicine, physical therapists, occupational therapists, pediatric neurology, pediatric urology, and psychological counselors, with the key goals of achieving functional independence and improving quality of life. Treatment begins immediately after birth and continues into adulthood.

Physical and occupational therapy (early intensive rehabilitation): passive stretching and range-of-motion exercises starting immediately after birth are the basic treatment. Passive stretching repeated several times a day stretches the periarticular fibrotic tissue to increase range of motion. After stretching, the corrected position is maintained with a splint or cast. Occupational therapists are responsible for the use of assistive devices to improve hand and arm function and for training in eating, dressing, and writing skills.

Serial casting: the Ponseti method for clubfoot (serial casting followed by percutaneous Achilles tenotomy and nighttime foot abduction brace) requires more casts and has a higher recurrence rate in AMC than in ordinary clubfoot, but is used as an effective first-line treatment. Serial casting is also applied to other joints such as the knee and elbow to gradually improve contractures.

Surgical treatment: when casting is insufficient for clubfoot, soft tissue surgery (tendon transfer, tendon lengthening, capsulotomy) is performed. In severe cases, bony surgery of the foot (calcaneal osteotomy, talectomy) is also needed. Hip dislocation is corrected by manual reduction or surgical reduction and osteotomy. Tendon transfer, capsulotomy, and in some cases lower limb lengthening surgery (Ilizarov method) are used for knee flexion and extension contractures. For scoliosis, brace treatment is recommended for a Cobb angle of 25–30 degrees or more, and surgical correction (spinal fusion) for 40–50 degrees or more.

Orthoses: lower limb orthoses (AFO: ankle-foot orthosis, KAFO: knee-ankle-foot orthosis) and upper limb orthoses (wrist and hand orthoses) are used long term to maintain the corrected position after surgery, assist function, and prevent recurrence. Power wheelchairs, walking aids (walker, crutch), and upper limb assistive devices are also used to achieve functional independence. Regular replacement of orthoses with growth and functional assessment are needed.

11. Prognosis

The prognosis of arthrogryposis multiplex congenita varies greatly according to the type of AMC, the number and location of affected joints, associated malformations, and the timing and intensity of treatment. Overall, intelligence and cognitive function are normal when there are no accompanying central nervous system abnormalities, which is an important positive prognostic factor in the rehabilitation and education of AMC patients.

Independent walking and performance of daily activities: about 50–60% of AMC patients achieve independent walking by adulthood, and this proportion depends greatly on the intensity of early physical therapy and surgical correction. When lower limb involvement is severe, mobility using orthoses, wheelchairs, and crutches is possible. Upper limb function varies with the degree of upper limb involvement, and independence in daily living can be increased through active occupational therapy and assistive devices.

Recurrence of contractures: in AMC, contractures are non-progressive, but they tend to recur after surgical correction during periods of growth (especially infancy and the adolescent growth spurt). Continued orthosis use and regular stretching are needed to prevent recurrence. Scoliosis also tends to progress during growth, so regular follow-up is important.

Social prognosis: many AMC patients achieve schooling, college entry, employment, and independent living. When intellectual ability is normal, academic achievement is similar to that of the general population. However, psychological difficulties due to physical limitations, repeated surgeries, and appearance differences may accompany the condition, so psychological counseling and peer support groups are important. Employment rates in adulthood depend on the level of physical function, but with appropriate vocational rehabilitation and assistive devices many achieve economic independence.

Life expectancy: the life expectancy of AMC patients without central nervous system abnormalities or serious visceral malformations is nearly similar to that of the general population. Severe respiratory failure, reduced lung function due to scoliosis, and complications of repeated surgery can threaten life, but with advances in modern medicine these complications are also managed effectively.

12. Prevention

Complete primary prevention of arthrogryposis multiplex congenita is currently not possible. However, secondary and tertiary prevention strategies such as prenatal genetic diagnosis in families with genetic causes, management of maternal risk factors, and prevention of recurrence after surgery are important.

Genetic counseling and prenatal diagnosis: for families of AMC patients, counseling with a genetic counselor evaluates identification of the causative gene, recurrence risk, and whether prenatal diagnosis is possible. When an autosomal recessive (AR) cause is identified and both parents are carriers, the recurrence risk is 25%, and fetal involvement can be determined by genetic analysis through prenatal CVS or amniocentesis. Preimplantation genetic testing (PGT) is also possible.

Management of maternal risk factors: maternal myasthenia gravis, multiple sclerosis, and neuromuscular diseases are treated appropriately before and during pregnancy to prevent antibody transfer to the fetus or deterioration of the intrauterine environment. Because high fever during pregnancy (fever in early pregnancy) can be harmful to fetal neurodevelopment, early antipyretic treatment is recommended. When oligohydramnios is found, improvement of fetal movement is sought through evaluation of the cause and obstetric management.

Prevention of recurrence after surgery (tertiary prevention): recurrence of contractures is minimized by continuing orthosis use and regular stretching after corrective surgery. Recurrence of scoliosis and hip dislocation is detected early and corrected through orthopedic follow-up during growth. Regular follow-up with the multidisciplinary team is key to improving long-term prognosis. Thorough education of patients and families (stretching methods, orthosis use, signs of recurrence) is the foundation of successful long-term management.

13. References

  1. Hall JG. Arthrogryposis multiplex congenita: etiology, genetics, classification, diagnostic approach, and general aspects. J Pediatr Orthop B. 1997;6(3):159-166. PMID: 9260642.

  2. Hall JG, Aldinger KA, Tanaka KI. Amyoplasia revisited. Am J Med Genet A. 2014;164A(3):700-730. DOI: 10.1002/ajmg.a.36395. PMID: 24357497.

  3. Bamshad M, Van Heest AE, Pleasure D. Arthrogryposis: a review and update. J Bone Joint Surg Am. 2009;91 Suppl 4:40-46. DOI: 10.2106/JBJS.I.00281. PMID: 19571066.

  4. Laville JM, Lakermance P, Limouzy F. Larsen's syndrome: review of the literature and analysis of thirty-eight cases. J Pediatr Orthop. 1994;14(1):63-73. PMID: 8113375.

  5. Bayram Y, Karaca E, Akdemir ZH, et al. Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin. J Clin Invest. 2016;126(2):762-778. DOI: 10.1172/JCI84457. PMID: 26752648.

  6. Haliloglu G, Topaloglu H. Arthrogryposis and fetal hypomobility syndrome. Handb Clin Neurol. 2013;113:1311-1319. DOI: 10.1016/B978-0-444-59565-2.00002-3. PMID: 23622361.

  7. Staheli L, Hall JG, Jaffe KM, Paholke DO (eds). Arthrogryposis: A Text Atlas. Cambridge University Press; 1998.

  8. Kowalczyk B, Felus J. Ponseti approach for the treatment of arthrogryposis-related clubfeet. Clin Orthop Relat Res. 2015;473(4):1299-1305. DOI: 10.1007/s11999-014-3817-x. PMID: 25096902.

  9. Kalampokas E, Kalampokas T, Sofoudis C, et al. Diagnosing arthrogryposis multiplex congenita: a review. ISRN Obstet Gynecol. 2012;2012:264918. DOI: 10.5402/2012/264918. PMID: 23209928.

  10. Lowry RB, Sibbald B, Bedard T, Hall JG. Prevalence of multiple congenital contractures including arthrogryposis multiplex congenita in Alberta, Canada, and a review of causation. Am J Med Genet A. 2010;152A(6):1335-1340. DOI: 10.1002/ajmg.a.33579. PMID: 20503310.